SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Knight who wrote (692)7/1/1998 12:03:00 PM
From: Robert Knight  Read Replies (1) of 1510
 
FWIW, my take on todays trading is that the people who have a vested interest in taking the stock lower are utlizing this opportunity to mitigate their exposure, as well as put a negative spin on what might be coming from Geneva. Whether people want to brush it off is their perogative as there is a documented short position of 1.7 million shares. What would you do if you were in their shoes? As far as buying, it appears that the institutions are content to wait...

I post this opinion because I'm sure some are wondering why the stock is dropping in light of the rumored bullish news that is suppose to be coming from Geneva. If you believe in what has been stated by the principals at IMNR & AGPH, the news will be good. I'm off to see the wizard.....

Robert
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext